IBM International Business Machines | $253.88 +0.4% | 5/21/2026 | | Reiterated Rating | | Outperform | 00.00% | View details for Wedbush rating of International Business Machines (NYSE:IBM) on 5/21/2026 |
NVDA NVIDIA | $215.33 -1.9% | 5/21/2026 | | Boost Price Target | $300.00 ➝ $330.00 | Outperform | 00.00% | View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 5/21/2026 |
GLOB Globant | $40.14 -1.2% | 5/18/2026 | | Reiterated Rating | | Outperform | 00.00% | View details for Wedbush rating of Globant (NYSE:GLOB) on 5/18/2026 |
LRMR Larimar Therapeutics | $3.45 -3.4% | 5/18/2026 | | Lower Price Target | $13.00 ➝ $12.00 | Outperform | 00.00% | View details for Wedbush rating of Larimar Therapeutics (NASDAQ:LRMR) on 5/18/2026 |
NVDA NVIDIA | $215.33 -1.9% | 5/18/2026 | | Reiterated Rating | $300.00 | Buy | 00.00% | View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 5/18/2026 |
GLOB Globant | $40.14 -1.2% | 5/15/2026 | | Set Price Target | $54.00 | | 00.00% | View details for Wedbush rating of Globant (NYSE:GLOB) on 5/15/2026 |
DT Dynatrace | $41.33 +5.6% | 5/15/2026 | | Set Price Target | $48.00 | | 00.00% | View details for Wedbush rating of Dynatrace (NYSE:DT) on 5/15/2026 |
SOLV Solventum | $76.92 +0.2% | 5/15/2026 | | Initiated Coverage | $94.00 | Outperform | 00.00% | View details for Wedbush rating of Solventum (NYSE:SOLV) on 5/15/2026 |
SBUX Starbucks | $103.11 -1.0% | 5/14/2026 | | Initiated Coverage | | Neutral ➝ Outperform | 00.00% | View details for Wedbush rating of Starbucks (NASDAQ:SBUX) on 5/14/2026 |
ANRO Alto Neuroscience | $21.22 -1.5% | 5/14/2026 | | Boost Price Target | $21.00 ➝ $24.00 | Neutral | 00.00% | View details for Wedbush rating of Alto Neuroscience (NYSE:ANRO) on 5/14/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
KLRS Kalaris Therapeutics | $4.92 -3.9% | 5/14/2026 | | Initiated Coverage | $17.00 | Outperform | 00.00% | View details for Wedbush rating of Kalaris Therapeutics (NASDAQ:KLRS) on 5/14/2026 |
APRE Aprea Therapeutics | $0.95 +2.2% | 5/14/2026 | | Lower Price Target | $7.00 ➝ $6.00 | Outperform | 00.00% | View details for Wedbush rating of Aprea Therapeutics (NASDAQ:APRE) on 5/14/2026 |
AVTX Avalo Therapeutics | $16.35 -1.5% | 5/14/2026 | | Lower Price Target | $40.00 ➝ $34.00 | Outperform | 00.00% | View details for Wedbush rating of Avalo Therapeutics (NASDAQ:AVTX) on 5/14/2026 |
INOD Innodata | $95.48 -3.1% | 5/14/2026 | | Boost Price Target | $80.00 ➝ $100.00 | Outperform | 00.00% | View details for Wedbush rating of Innodata (NASDAQ:INOD) on 5/14/2026 |
KLRS Kalaris Therapeutics | $4.92 -3.9% | 5/14/2026 | | Initiated Coverage | $17.00 | Outperform | 00.00% | View details for Wedbush rating of Kalaris Therapeutics (NASDAQ:KLRS) on 5/14/2026 |
PL Planet Labs PBC | $44.39 +4.5% | 5/14/2026 | | Boost Price Target | $40.00 ➝ $50.00 | Outperform | 00.00% | View details for Wedbush rating of Planet Labs PBC (NYSE:PL) on 5/14/2026 |
STAA STAAR Surgical | $32.47 -1.0% | 5/14/2026 | | Upgrade | $26.00 ➝ $40.00 | Neutral ➝ Outperform | 00.00% | View details for Wedbush rating of STAAR Surgical (NASDAQ:STAA) on 5/14/2026 |
TNGX Tango Therapeutics | $20.24 -6.4% | 5/14/2026 | | Boost Price Target | $19.00 ➝ $33.00 | Outperform | 00.00% | View details for Wedbush rating of Tango Therapeutics (NASDAQ:TNGX) on 5/14/2026 |
TSEM Tower Semiconductor | $283.43 +1.6% | 5/14/2026 | | Boost Price Target | $140.00 ➝ $300.00 | Neutral | 00.00% | View details for Wedbush rating of Tower Semiconductor (NASDAQ:TSEM) on 5/14/2026 |
VOR Vor Biopharma | $14.33 -4.7% | 5/14/2026 | | Boost Price Target | $15.00 ➝ $18.00 | Neutral | 00.00% | View details for Wedbush rating of Vor Biopharma (NASDAQ:VOR) on 5/14/2026 |
ORCL Oracle | $192.13 +1.2% | 5/13/2026 | | Boost Price Target | $225.00 ➝ $275.00 | Outperform | 00.00% | View details for Wedbush rating of Oracle (NYSE:ORCL) on 5/13/2026 |
PEPG PepGen | $1.51 -1.9% | 5/13/2026 | | Lower Price Target | $5.00 ➝ $4.00 | Outperform | 00.00% | View details for Wedbush rating of PepGen (NASDAQ:PEPG) on 5/13/2026 |
AI C3.ai | $9.30 -0.3% | 5/13/2026 | | Reiterated Rating | $15.00 | Outperform | 00.00% | View details for Wedbush rating of C3.ai (NYSE:AI) on 5/13/2026 |
DDI DoubleDown Interactive | $11.97 -1.2% | 5/13/2026 | | Lower Price Target | $21.00 ➝ $15.00 | Outperform | 00.00% | View details for Wedbush rating of DoubleDown Interactive (NASDAQ:DDI) on 5/13/2026 |
MSFT Microsoft | $418.57 -0.1% | 5/13/2026 | | Reiterated Rating | $575.00 | Outperform | 00.00% | View details for Wedbush rating of Microsoft (NASDAQ:MSFT) on 5/13/2026 |
OKLO Oklo | $65.76 +1.0% | 5/13/2026 | | Reiterated Rating | $110.00 | Outperform | 00.00% | View details for Wedbush rating of Oklo (NYSE:OKLO) on 5/13/2026 |
SLDB Solid Biosciences | $6.62 +1.8% | 5/13/2026 | | Lower Price Target | $17.00 ➝ $16.00 | Outperform | 00.00% | View details for Wedbush rating of Solid Biosciences (NASDAQ:SLDB) on 5/13/2026 |
CINT CI&T | $3.37 -4.0% | 5/12/2026 | | Lower Price Target | $9.00 ➝ $7.00 | Outperform | 00.00% | View details for Wedbush rating of CI&T (NYSE:CINT) on 5/12/2026 |
EIKN EIKN | $10.91 -2.2% | 5/12/2026 | | Lower Price Target | $7.00 ➝ $5.00 | Underperform | 00.00% | View details for Wedbush rating of EIKN (NASDAQ:EIKN) on 5/12/2026 |
GETY Getty Images | $1.07 +2.4% | 5/12/2026 | | Reiterated Rating | $7.00 | Outperform | 00.00% | View details for Wedbush rating of Getty Images (NYSE:GETY) on 5/12/2026 |
NCMI National CineMedia | $2.99 -0.3% | 5/12/2026 | | Lower Price Target | $6.50 ➝ $6.00 | Outperform | 00.00% | View details for Wedbush rating of National CineMedia (NASDAQ:NCMI) on 5/12/2026 |
NTLA Intellia Therapeutics | $12.60 +1.9% | 5/12/2026 | | Reiterated Rating | $12.00 | Neutral | 00.00% | View details for Wedbush rating of Intellia Therapeutics (NASDAQ:NTLA) on 5/12/2026 |
USAR USA Rare Earth | $25.30 +4.2% | 5/12/2026 | | Boost Price Target | $29.00 ➝ $35.00 | Outperform | 00.00% | View details for Wedbush rating of USA Rare Earth (NASDAQ:USAR) on 5/12/2026 |
ARTV Artiva Biotherapeutics | $7.87 -1.5% | 5/11/2026 | | Boost Price Target | $23.00 ➝ $40.00 | Outperform | 00.00% | View details for Wedbush rating of Artiva Biotherapeutics (NASDAQ:ARTV) on 5/11/2026 |
BUR Burford Capital | $4.53 -3.7% | 5/11/2026 | | Boost Price Target | $4.75 ➝ $5.00 | Neutral | 00.00% | View details for Wedbush rating of Burford Capital (NYSE:BUR) on 5/11/2026 |
CGON CG Oncology | $64.25 -0.5% | 5/11/2026 | | Boost Price Target | $77.00 ➝ $80.00 | Outperform | 00.00% | View details for Wedbush rating of CG Oncology (NASDAQ:CGON) on 5/11/2026 |
GM General Motors | $78.81 +2.1% | 5/11/2026 | | Reiterated Rating | $95.00 | Outperform | 00.00% | View details for Wedbush rating of General Motors (NYSE:GM) on 5/11/2026 |
IMA ImageneBio | $5.56 +0.7% | 5/11/2026 | | Reiterated Rating | | Underperform | 00.00% | View details for Wedbush rating of ImageneBio (NASDAQ:IMA) on 5/11/2026 |
JBIO Jade Biosciences | $22.21 -5.3% | 5/11/2026 | | Boost Price Target | $24.00 ➝ $34.00 | Outperform | 00.00% | View details for Wedbush rating of Jade Biosciences (NASDAQ:JBIO) on 5/11/2026 |
NKTR Nektar Therapeutics | $66.61 -2.9% | 5/11/2026 | | Lower Price Target | $95.00 ➝ $80.00 | Neutral | 00.00% | View details for Wedbush rating of Nektar Therapeutics (NASDAQ:NKTR) on 5/11/2026 |
The SpaceX filing is public. The window is closing. (Ad) SpaceX just filed its S-1. The IPO is confirmed for June 12 - $75 billion, ticker SPCX, potentially the largest in history. The 21-bank syndicate has already locked up shares, so retail investors won't get access.
But the S-1 exposed one publicly traded company Musk cannot operate without - and it's still cheap. Dylan Jovine is releasing the ticker free before June 12 changes the price. Get the ticker before the SpaceX IPO reprices everything on June 12 |
TTD Trade Desk | $22.38 +5.2% | 5/8/2026 | | Set Price Target | $23.00 ➝ $21.00 | Neutral | 00.00% | View details for Wedbush rating of Trade Desk (NASDAQ:TTD) on 5/8/2026 |
COIN Coinbase Global | $184.99 -4.4% | 5/8/2026 | | Set Price Target | $224.00 | | 00.00% | View details for Wedbush rating of Coinbase Global (NASDAQ:COIN) on 5/8/2026 |
AAPL Apple | $308.82 +1.3% | 5/8/2026 | | Reiterated Rating | $350.00 ➝ $400.00 | Outperform | 00.00% | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 5/8/2026 |
CGEM Cullinan Therapeutics | $13.84 -1.0% | 5/8/2026 | | Boost Price Target | $36.00 ➝ $37.00 | Outperform | 00.00% | View details for Wedbush rating of Cullinan Therapeutics (NASDAQ:CGEM) on 5/8/2026 |
CLYM Climb Bio | $11.00 +0.8% | 5/8/2026 | | Boost Price Target | $15.00 ➝ $17.00 | Outperform | 00.00% | View details for Wedbush rating of Climb Bio (NASDAQ:CLYM) on 5/8/2026 |
CRSR Corsair Gaming | $7.70 +11.1% | 5/8/2026 | | Boost Price Target | $7.00 ➝ $8.00 | Outperform | 00.00% | View details for Wedbush rating of Corsair Gaming (NASDAQ:CRSR) on 5/8/2026 |
DNLI Denali Therapeutics | $18.64 -3.4% | 5/8/2026 | | Lower Price Target | $25.00 ➝ $23.00 | Outperform | 00.00% | View details for Wedbush rating of Denali Therapeutics (NASDAQ:DNLI) on 5/8/2026 |
INOD Innodata | $95.48 -3.1% | 5/8/2026 | | Boost Price Target | $75.00 ➝ $80.00 | Outperform | 00.00% | View details for Wedbush rating of Innodata (NASDAQ:INOD) on 5/8/2026 |
JANX Janux Therapeutics | $14.52 +0.8% | 5/8/2026 | | Lower Price Target | $45.00 ➝ $36.00 | Outperform | 00.00% | View details for Wedbush rating of Janux Therapeutics (NASDAQ:JANX) on 5/8/2026 |
MP MP Materials | $64.42 +4.3% | 5/8/2026 | | Boost Price Target | $90.00 ➝ $100.00 | Outperform | 00.00% | View details for Wedbush rating of MP Materials (NYSE:MP) on 5/8/2026 |
PRAX Praxis Precision Medicines | $343.56 -2.0% | 5/8/2026 | | Boost Price Target | $130.00 ➝ $166.00 | Underperform | 00.00% | View details for Wedbush rating of Praxis Precision Medicines (NASDAQ:PRAX) on 5/8/2026 |
STTK Shattuck Labs | $6.10 +0.2% | 5/8/2026 | | Boost Price Target | $8.00 ➝ $11.00 | Outperform | 00.00% | View details for Wedbush rating of Shattuck Labs (NASDAQ:STTK) on 5/8/2026 |
U Unity Software | $25.50 -0.2% | 5/8/2026 | | Boost Price Target | $30.00 ➝ $32.00 | Outperform | 00.00% | View details for Wedbush rating of Unity Software (NYSE:U) on 5/8/2026 |
APP AppLovin | $481.68 -0.9% | 5/7/2026 | | Reiterated Rating | $640.00 | Outperform | 00.00% | View details for Wedbush rating of AppLovin (NASDAQ:APP) on 5/7/2026 |
BCRX BioCryst Pharmaceuticals | $8.29 -1.0% | 5/7/2026 | | Lower Price Target | $22.00 ➝ $21.00 | Outperform | 00.00% | View details for Wedbush rating of BioCryst Pharmaceuticals (NASDAQ:BCRX) on 5/7/2026 |
CCRN Cross Country Healthcare | $13.05
| 5/7/2026 | | Downgrade | $15.00 ➝ $13.25 | Outperform ➝ Hold | 00.00% | View details for Wedbush rating of Cross Country Healthcare (NASDAQ:CCRN) on 5/7/2026 |
DDOG Datadog | $222.32 +2.0% | 5/7/2026 | | Boost Price Target | $190.00 ➝ $220.00 | Outperform | 00.00% | View details for Wedbush rating of Datadog (NASDAQ:DDOG) on 5/7/2026 |
FUBO fuboTV | $9.78 +7.0% | 5/7/2026 | | Lower Price Target | $24.00 ➝ $19.00 | Outperform | 00.00% | View details for Wedbush rating of fuboTV (NYSE:FUBO) on 5/7/2026 |
QLYS Qualys | $102.37 +1.5% | 5/7/2026 | | Lower Price Target | $155.00 ➝ $125.00 | Outperform | 00.00% | View details for Wedbush rating of Qualys (NASDAQ:QLYS) on 5/7/2026 |
RVMD Revolution Medicines | $151.56 -1.4% | 5/7/2026 | | Boost Price Target | $165.00 | Outperform | 00.00% | View details for Wedbush rating of Revolution Medicines (NASDAQ:RVMD) on 5/7/2026 |
TASK TaskUs | $6.16 +0.7% | 5/7/2026 | | Lower Price Target | $14.00 ➝ $12.00 | Outperform | 00.00% | View details for Wedbush rating of TaskUs (NASDAQ:TASK) on 5/7/2026 |
AVTX Avalo Therapeutics | $16.35 -1.5% | 5/6/2026 | | Boost Price Target | $29.00 ➝ $40.00 | Outperform | 00.00% | View details for Wedbush rating of Avalo Therapeutics (NASDAQ:AVTX) on 5/6/2026 |
DNTH Dianthus Therapeutics | $86.48 -3.5% | 5/6/2026 | | Boost Price Target | $103.00 ➝ $105.00 | Outperform | 00.00% | View details for Wedbush rating of Dianthus Therapeutics (NASDAQ:DNTH) on 5/6/2026 |
HURN Huron Consulting Group | $105.46 +0.1% | 5/6/2026 | | Reiterated Rating | $160.00 | Outperform | 00.00% | View details for Wedbush rating of Huron Consulting Group (NASDAQ:HURN) on 5/6/2026 |
IBM International Business Machines | $253.88 +0.4% | 5/6/2026 | | Reiterated Rating | $320.00 | Outperform | 00.00% | View details for Wedbush rating of International Business Machines (NYSE:IBM) on 5/6/2026 |
LOGI Logitech International | $112.63 +6.5% | 5/6/2026 | | Reiterated Rating | $135.00 | Outperform | 00.00% | View details for Wedbush rating of Logitech International (NASDAQ:LOGI) on 5/6/2026 |
NBIX Neurocrine Biosciences | $156.70 +0.8% | 5/6/2026 | | Boost Price Target | $166.00 ➝ $176.00 | Outperform | 00.00% | View details for Wedbush rating of Neurocrine Biosciences (NASDAQ:NBIX) on 5/6/2026 |
PTGX Protagonist Therapeutics | $99.19 -2.8% | 5/6/2026 | | Boost Price Target | $112.00 ➝ $118.00 | Outperform | 00.00% | View details for Wedbush rating of Protagonist Therapeutics (NASDAQ:PTGX) on 5/6/2026 |
RARE Ultragenyx Pharmaceutical | $23.39 -1.3% | 5/6/2026 | | Lower Price Target | $27.00 ➝ $26.00 | Neutral | 00.00% | View details for Wedbush rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 5/6/2026 |
SMCI Super Micro Computer | $35.58 +6.3% | 5/6/2026 | | Lower Price Target | $42.00 ➝ $34.00 | Neutral | 00.00% | View details for Wedbush rating of Super Micro Computer (NASDAQ:SMCI) on 5/6/2026 |
PAY Paymentus | $23.45 -0.1% | 5/5/2026 | | Boost Price Target | $32.00 ➝ $36.00 | Outperform | 00.00% | View details for Wedbush rating of Paymentus (NYSE:PAY) on 5/5/2026 |
TVTX Travere Therapeutics | $44.43 -0.7% | 5/5/2026 | | Boost Price Target | $53.00 ➝ $55.00 | Outperform | 00.00% | View details for Wedbush rating of Travere Therapeutics (NASDAQ:TVTX) on 5/5/2026 |
CATX Perspective Therapeutics | $3.98 +2.8% | 5/5/2026 | | Reiterated Rating | $11.00 | Outperform | 00.00% | View details for Wedbush rating of Perspective Therapeutics (NYSEAMERICAN:CATX) on 5/5/2026 |
NUVB Nuvation Bio | $4.73 -1.4% | 5/5/2026 | | Reiterated Rating | $11.00 | Outperform | 00.00% | View details for Wedbush rating of Nuvation Bio (NYSE:NUVB) on 5/5/2026 |
PLTR Palantir Technologies | $136.88 -0.4% | 5/5/2026 | | Reiterated Rating | $230.00 | Outperform | 00.00% | View details for Wedbush rating of Palantir Technologies (NASDAQ:PLTR) on 5/5/2026 |
PYXS Pyxis Oncology | $1.96 +1.0% | 5/5/2026 | | Initiated Coverage | $6.00 | Outperform | 00.00% | View details for Wedbush rating of Pyxis Oncology (NASDAQ:PYXS) on 5/5/2026 |
SION Sionna Therapeutics | $41.13 -1.5% | 5/5/2026 | | Initiated Coverage | $53.00 | Outperform | 00.00% | View details for Wedbush rating of Sionna Therapeutics (NASDAQ:SION) on 5/5/2026 |
ABNB Airbnb | $132.35 -1.4% | 5/4/2026 | | Upgrade | | Neutral | 00.00% | View details for Wedbush rating of Airbnb (NASDAQ:ABNB) on 5/4/2026 |
AMD Advanced Micro Devices | $467.51 +4.0% | 5/4/2026 | | Boost Price Target | $290.00 ➝ $400.00 | Outperform | 00.00% | View details for Wedbush rating of Advanced Micro Devices (NASDAQ:AMD) on 5/4/2026 |
GFS GlobalFoundries | $85.64 +5.3% | 5/4/2026 | | Reiterated Rating | $50.00 | Neutral | 00.00% | View details for Wedbush rating of GlobalFoundries (NASDAQ:GFS) on 5/4/2026 |
IONQ IonQ | $63.54 +7.9% | 5/4/2026 | | Reiterated Rating | $60.00 | Outperform | 00.00% | View details for Wedbush rating of IonQ (NYSE:IONQ) on 5/4/2026 |
SION Sionna Therapeutics | $41.13 -1.5% | 5/4/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Wedbush rating of Sionna Therapeutics (NASDAQ:SION) on 5/4/2026 |
TMC TMC the metals | $5.40 +2.7% | 5/4/2026 | | Boost Price Target | $8.00 ➝ $10.00 | Outperform | 00.00% | View details for Wedbush rating of TMC the metals (NASDAQ:TMC) on 5/4/2026 |
RBLX Roblox | $48.23 +4.5% | 5/1/2026 | | Downgrade | | Hold ➝ Neutral | 00.00% | View details for Wedbush rating of Roblox (NYSE:RBLX) on 5/1/2026 |
RBLX Roblox | $48.23 +4.5% | 5/1/2026 | | Lower Price Target | $90.00 ➝ $65.00 | Outperform | 00.00% | View details for Wedbush rating of Roblox (NYSE:RBLX) on 5/1/2026 |
CHKP Check Point Software Technologies | $133.63 +1.4% | 5/1/2026 | | Lower Price Target | $210.00 ➝ $160.00 | Outperform | 00.00% | View details for Wedbush rating of Check Point Software Technologies (NASDAQ:CHKP) on 5/1/2026 |
RITM Rithm Capital | $9.27 +0.1% | 5/1/2026 | | Lower Price Target | $14.00 ➝ $12.50 | Outperform | 00.00% | View details for Wedbush rating of Rithm Capital (NYSE:RITM) on 5/1/2026 |
ROKU Roku | $125.55 +0.4% | 5/1/2026 | | Boost Price Target | $140.00 ➝ $155.00 | Outperform | 00.00% | View details for Wedbush rating of Roku (NASDAQ:ROKU) on 5/1/2026 |
AAPL Apple | $308.82 +1.3% | 5/1/2026 | | Reiterated Rating | $350.00 | Outperform | 00.00% | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 5/1/2026 |
FNMA Fannie Mae | $7.19 +0.4% | 5/1/2026 | | Downgrade | $8.00 | Outperform ➝ Neutral | 00.00% | View details for Wedbush rating of Fannie Mae (OTCMKTS:FNMA) on 5/1/2026 |
June 12: $100 Turns Into $100,000? (Ad) The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before major runs - says the window to get in early is closing fast.
Brown is showing investors how to claim a stake in Elon Musk's company before it hits the public markets. Once the IPO happens, this pre-public opportunity disappears. Click here to see how to get ahead of the SpaceX IPO |
RNAC Cartesian Therapeutics | $6.75 +1.0% | 5/1/2026 | | Reiterated Rating | $38.00 | Outperform | 00.00% | View details for Wedbush rating of Cartesian Therapeutics (NASDAQ:RNAC) on 5/1/2026 |
TENB Tenable | $25.45 +1.1% | 4/30/2026 | | Lower Price Target | $32.00 ➝ $27.00 | Outperform | 00.00% | View details for Wedbush rating of Tenable (NASDAQ:TENB) on 4/30/2026 |
SIMO Silicon Motion Technology | $276.14 +4.8% | 4/30/2026 | | Boost Price Target | $180.00 ➝ $230.00 | Outperform | 00.00% | View details for Wedbush rating of Silicon Motion Technology (NASDAQ:SIMO) on 4/30/2026 |
MCS Marcus | $18.11 -1.2% | 4/30/2026 | | Boost Price Target | $22.00 ➝ $23.00 | Outperform | 00.00% | View details for Wedbush rating of Marcus (NYSE:MCS) on 4/30/2026 |
BIIB Biogen | $193.76 +2.3% | 4/30/2026 | | Boost Price Target | $191.00 ➝ $196.00 | Neutral | 00.00% | View details for Wedbush rating of Biogen (NASDAQ:BIIB) on 4/30/2026 |
CTSH Cognizant Technology Solutions | $52.75 +0.8% | 4/30/2026 | | Lower Price Target | $61.00 ➝ $56.00 | Neutral | 00.00% | View details for Wedbush rating of Cognizant Technology Solutions (NASDAQ:CTSH) on 4/30/2026 |
MSFT Microsoft | $418.57 -0.1% | 4/30/2026 | | Reiterated Rating | $575.00 | Outperform | 00.00% | View details for Wedbush rating of Microsoft (NASDAQ:MSFT) on 4/30/2026 |
U Unity Software | $25.50 -0.2% | 4/30/2026 | | Reiterated Rating | $30.00 | Outperform | 00.00% | View details for Wedbush rating of Unity Software (NYSE:U) on 4/30/2026 |
ACRS Aclaris Therapeutics | $4.52 -0.4% | 4/29/2026 | | Boost Price Target | $8.00 ➝ $10.00 | Outperform | 00.00% | View details for Wedbush rating of Aclaris Therapeutics (NASDAQ:ACRS) on 4/29/2026 |
SNDK Sandisk | $1,478.69 -4.1% | 4/29/2026 | | Boost Price Target | $740.00 ➝ $1,200.00 | Outperform | 00.00% | View details for Wedbush rating of Sandisk (NASDAQ:SNDK) on 4/29/2026 |